191 related articles for article (PubMed ID: 19697649)
1. Unilateral masseter muscle hypertrophy: morphofunctional analysis of the relapse after treatment with botulinum toxin.
Peretta R; Melison M; Meneghello R; Comelli D; Guarda L; Galzignato PF; Concheri G; Ferronato G
Cranio; 2009 Jul; 27(3):200-10. PubMed ID: 19697649
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type A in the management of masseter muscle hypertrophy.
Castro WH; Gomez RS; Da Silva Oliveira J; Moura MD; Gomez RS
J Oral Maxillofac Surg; 2005 Jan; 63(1):20-4. PubMed ID: 15635552
[TBL] [Abstract][Full Text] [Related]
3. [The use of botulinum toxin type A in masseter muscle hypertrophy: long-term effects and lasting improvement].
Aydil B; Başaran B; Unsaler S; Süoğlu Y
Kulak Burun Bogaz Ihtis Derg; 2012; 22(5):249-53. PubMed ID: 22991984
[TBL] [Abstract][Full Text] [Related]
4. Classification of masseter hypertrophy for tailored botulinum toxin type A treatment.
Xie Y; Zhou J; Li H; Cheng C; Herrler T; Li Q
Plast Reconstr Surg; 2014 Aug; 134(2):209e-218e. PubMed ID: 25068343
[TBL] [Abstract][Full Text] [Related]
5. Effects of two different units of botulinum toxin type a evaluated by computed tomography and electromyographic measurements of human masseter muscle.
Kim JH; Shin JH; Kim ST; Kim CY
Plast Reconstr Surg; 2007 Feb; 119(2):711-7. PubMed ID: 17230111
[TBL] [Abstract][Full Text] [Related]
6. Exploring botulinum toxin's impact on masseter hypertrophy: a randomized, triple-blinded clinical trial.
de Souza Nobre BB; Rezende L; Barbosa Câmara-Souza M; Sanchez-Ayala A; Blass R; Carbone AC; Manso AC; Ernberg M; Christidis N; De la Torre Canales G
Sci Rep; 2024 Jun; 14(1):14522. PubMed ID: 38914688
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin for masseter hypertrophy.
Al-Muharraqi MA; Fedorowicz Z; Al Bareeq J; Al Bareeq R; Nasser M
Cochrane Database Syst Rev; 2009 Jan; (1):CD007510. PubMed ID: 19160335
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional CT might be a potential evaluation modality in correction of asymmetrical masseter muscle hypertrophy by botulinum toxin injection.
No YA; Ahn BH; Kim BJ; Kim MN; Hong CK
J Cosmet Laser Ther; 2016; 18(2):113-5. PubMed ID: 26073120
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiologic change and facial contour following botulinum toxin A injection in square faces.
Lee CJ; Kim SG; Kim YJ; Han JY; Choi SH; Lee SI
Plast Reconstr Surg; 2007 Sep; 120(3):769-778. PubMed ID: 17700130
[TBL] [Abstract][Full Text] [Related]
10. [Noninvasive monitoring of changes in the structure and function of masseter muscles after the injection of botulinum toxin type A].
Guo Z; Diao X; Xia W; Liu T; Chen Y; Zheng J; Zhou Z; Yang P; Zhu J
Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Nov; 32(6):437-40. PubMed ID: 30067323
[TBL] [Abstract][Full Text] [Related]
11. Lower facial remodeling with botulinum toxin type A for the treatment of masseter hypertrophy.
Klein FH; Brenner FM; Sato MS; Robert FM; Helmer KA
An Bras Dermatol; 2014; 89(6):878-84. PubMed ID: 25387491
[TBL] [Abstract][Full Text] [Related]
12. Management of unilateral idiopathic masseter muscle hypertrophy with botulinum toxin type A.
Nilesh K; Dharamsi R; Patil P; Mate P
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33462041
[TBL] [Abstract][Full Text] [Related]
13. Treatment of masseteric hypertrophy with botulinum toxin: a report of two cases.
Baş B; Ozan B; Muğlali M; Celebi N
Med Oral Patol Oral Cir Bucal; 2010 Jul; 15(4):e649-52. PubMed ID: 20173718
[TBL] [Abstract][Full Text] [Related]
14. A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement.
To EW; Ahuja AT; Ho WS; King WW; Wong WK; Pang PC; Hui AC
Br J Plast Surg; 2001 Apr; 54(3):197-200. PubMed ID: 11254408
[TBL] [Abstract][Full Text] [Related]
15. Aesthetic uses of botulinum toxin A.
Niamtu J
J Oral Maxillofac Surg; 1999 Oct; 57(10):1228-33. PubMed ID: 10513870
[No Abstract] [Full Text] [Related]
16. Assessment of changes in masseter muscle by three-dimensional close-range photogrammetry after Botulinum toxin type-A injection: A case report with review of literature.
Bayrak NB; Zeybek M; Sanlioglu I; Dolanmaz D
J Pak Med Assoc; 2019 Mar; 69(3):418-422. PubMed ID: 30890839
[TBL] [Abstract][Full Text] [Related]
17. Use of botulinum toxin type A for the treatment of masseteric muscle hypertrophy.
Arikan OK; Tan FU; Kendi T; Koc C
J Otolaryngol; 2006 Feb; 35(1):40-3. PubMed ID: 16527016
[TBL] [Abstract][Full Text] [Related]
18. Prolonging the duration of masseter muscle reduction by adjusting the masticatory movements after the treatment of masseter muscle hypertrophy with botulinum toxin type a injection.
Wei J; Xu H; Dong J; Li Q; Dai C
Dermatol Surg; 2015 Jan; 41 Suppl 1():S101-9. PubMed ID: 25548838
[TBL] [Abstract][Full Text] [Related]
19. The treatment of masseter hypertrophy with botulinum toxin type A.
Al-Ahmad HT; Al-Qudah MA
Saudi Med J; 2006 Mar; 27(3):397-400. PubMed ID: 16532107
[TBL] [Abstract][Full Text] [Related]
20. Effect of botulinum toxin on pressure pain threshold and EMG power spectrum of masseter muscle during sustained fatiguing contraction.
Kim C; McCall WD; Kim YK; Chung JW
Am J Phys Med Rehabil; 2010 Sep; 89(9):736-43. PubMed ID: 20729652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
